knowledge -WSS

knowledge

author：hotspot 2025-09-14 11:51:37 - browse：9268

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Is mRNA technology the right fit for flu shots? Experts aren’t so sure

WSS

With clinical trial data readouts, here's how to spot spin

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

OTC birth control: A brief history of over the counter pill design

Gilgo Beach: Police identify another victim in serial killing investigation

UnitedHealth’s Optum accused of antitrust violations in California

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

hotspot

knowledge

hotspot

Peter Hotez and the public health issue of online harassment

30 years of 'Listening to Prozac'

Supreme Court strikes down use of affirmative action

What don’t we know about an Alzheimer’s drug side effect?

The high cost of giving birth even with insurance

Flagship Pioneering launches a new biotech in two countries

Peter Hotez and the public health issue of online harassment

Influencer to be charged after chaos erupts in New York City's Union Square

What does generative AI mean for health care? We asked experts

What the cancer research community can learn from the Covid response

Wikipedia

ReNAgade cuts staff seven months after raising $300 million

'Ancient DNA,' 23andMe reveal African American ancestries

How to pay for weight loss drugs and save Medicare

Rep. Raul Ruiz on the physician shortage and more

Microsoft strikes partnership with Duke Health to advance health AI

Cigna, Humana reportedly in talks to merge

knowledge

explore

hotspot

entertainment